Baebies

Baebies is a commercial-stage diagnostics company with a unique multifunctional platform, FINDER, powered by digital microfluidics. The platform is capable of running molecular, chemistry, coagulation, and immunoassay tests from a single drop of sample, delivering rapid results for near-patient use. The company has three key products: a CLIA-waived molecular test for Flu A/B and SARS-CoV-2, an FDA-cleared chemistry test for G6PD deficiency, and an anti-Factor Xa coagulation test with FDA Breakthrough Device designation. Baebies is positioned to address the growing demand for decentralized, rapid diagnostics across various healthcare settings.

Digital Microfluidics (DMF) using electrowetting for droplet manipulation on a printed circuit board, enabling multifunctional (molecular, chemistry, coagulation, immunoassay) diagnostic testing on a single, compact instrument (FINDER platform).

Baebies competes in the point-of-care diagnostics market against major players like Abbott (i-STAT, ID NOW), Roche (cobas Liat), QuidelOrtho, and BioMérieux, which offer dedicated platforms. Its key differentiation is the multifunctional capability of a single instrument, a niche where competitors like GenMark (ePlex) and LumiraDx have also played but with different technological approaches.